[ET Net News Agency, 31 January 2024] CARDIOFLOW-B (02160) rose 22.4% to HK$1.53,
breaking above the 20-D SMA of HK$1.41.
It hits an intra-day high of HK$1.53, and an intra-day low of HK$1.19. The total shares
traded was 13.08 million, with a value of HK$17.05m. The active buy/sell ratio is 52:48,
with net buying turnover of HK$667,350. FUTU SEC INT'L accounts for greatest net
responsive buying turnover of HK$3.03m, with volume weighted average price of HK$1.344.
BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$725,534,
with volume weighted average price of HK$1.303.
Basic Information
=================
----------------------------------
Nominal 1.530 % Chg +22.40%
High 1.530 Low 1.190
Shares Tr 13.08m Turnover 17.05m
10-D SMA 1.290 %H.V 50.919
20-D SMA 1.410 VWAP 1.303
50-D SMA 1.582 RSI14 56.655
----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 52:48, with net buying
turnover of HK$667,350
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
CARDIOFLOW-B (02160) 1.53 +22.40
GENSCRIPT BIO (01548) 12.94 -4.85
INNOVENT BIO (01801) 31.30 -1.73
JXR (01951) 2.16 -3.57
EVEREST MED-B (01952) 15.62 -4.05
WUXI BIO (02269) 20.35 -8.95
WUXI APPTEC (02359) 53.65 -4.71
BEIGENE (06160) 90.00 -4.15
ZAI LAB (09688) 16.84 -2.55
AKESO (09926) 39.55 -0.50
---------------------------------------------
(ed)